Working Towards Universal Implementation of Human Papillomavirus Vaccination to Prevent Cervical Cancer

Abstract

Human Papillomavirus (HPV) vaccination should be included in national immunization programs, as part of a comprehensive approach to cervical cancer prevention and control. The practical aspects of vaccine uptake are now the most important issue in HPV vaccine research from a public-health perspective. Increasing uptake, specifically in regions where disease burden is highest, will require thoughtful consideration of cost-effectiveness, innovative financing mechanisms, novel approaches to vaccine vehicle delivery and public acceptance. We review ongoing critical barriers and challenges to implementation of HPV vaccination. The aim of this paper is to review ongoing critical barriers and challenges to implementation of HPV vaccination.

Global Health: Role of HPV Testing in Resource Poor Environment

“…Vaccine coverage ranging from 55-75% can be achieved when delivery is school-based, health center based or combined with other health interventions [4,5]. However, widespread vaccination is not feasible due to sociocultural sensibilities, government distrust, and lack of patient anatomy and cost [6]. Secondary prevention in high-income countries with the Papanicolaou (Pap) smear has led to dramatic reduction of cervical cancer [7,8].…”

In Bangla There Is No Word for Vagina <br>—Reflections on Language, Sexual Health, and Women’s Access to Healthcare in Resource-Limited Countries

“…HPV-related cervical cancer has a long premalignant phase before transforming into a cancer and therefore this cancer can easily be diagnosed and eradicated by early screening with pap smears [10]. More recently, HPV vaccination has become available and widespread vaccination of both girls and boys could potentially lead to the disappearance of this disease [11]. Despite well established and inexpensive guidelines for detection, evaluation, and treatment, cervical cancer is a leading cause of cancer-related death in low-and middleincome countries (LMICs) due to lack of screening [12].…”